Gold..You sent an email to william gartner stating you wanted to Invest in GCDX...What has changed? What we know and believe is that the IP he is keeping a secret is LC Sentinel. LC Sentinel is a lung and breast cancer test in collaboration between Provista Diagnostics and AMDL Diagnostics and Radient. LC Sentinel is a combination of DR-70 a FDA approved reagent and Provista's IP..That is the reason the FDA is not shutting down GCDX.. Not sales as you stated, that is not true..imo Wolf
Below is an email from you to William Gartner...
Dear Mr. Gartner,
"I am intrigued by your recent press release about offering a new Lung Cancer Test.
How do you get your financing? Is there an opportunity for a private investor like me to invest, and if so, how would I accomplish that?
In researching GCDx, I am finding several rumors on the internet (particularly on InvestorsHub.com) that your company is merging with, or taking over, Radient Pharmaceuticals and/or Provista Diagnostics. Is there any truth to that rumor? What is your current business relationship with Radient Pharmaceuticals and Provista Diagnostics? Do you own RXPC stock?
I am concerned that Radient might be carrying a lot of debt -- if you are involved with taking over or merging with Radient, what kind of debt responsibilities are you incurring, and if I invest in your company, how would I know that my money is not going towards paying off Radient's debt?
Finally -- do you have any patents or patent applications for The Lung Cancer Test for Early Detection?
Thank you for your time,"
